99807-07-5

Upstream product

• 1313211-49-2 tert-butyl N-(4-acetonyloxyphenyl)carbamate 
• 6698-72-2 1-(4-nitrophenoxy)propan-2-one 
• 64-17-5 ethanol 

Downstream Products

• 1596360-88-1 ethyl 2-[(4-acetonyloxyphenyl)amino]acetate 
• 1596360-73-4 9H-fluoren-9-ylmethyl N-[(5S)-5-[[6-[[3-(4-acetonyloxyphenyl)-2,5-dioxo-imidazolidin-1-yl]methyl]-7-methyl-pyrrolo[2,3-d]pyrimidine-2-carbonyl]amino]-5-cyano-pentyl]carbamate 
• 1596360-30-3 6-[[3-(4-acetonyloxyphenyl)-2,5-dioxo-imidazolidin-1-yl]methyl]-N-[(1S)-5-amino-1-cyano-pentyl]-7-methyl-pyrrolo[2,3-d]pyrimidine-2-carboxamide 
• 1596359-97-5 1-(4-acetonyloxyphenyl)imidazolidine-2,4-dione 
• 1596360-51-8 methyl 6-[[3-(4-acetonyloxyphenyl)-2,5-dioxo-imidazolidin-1-yl]methyl]-7-methyl-pyrrolo[2,3-d]pyrimidine-2-carboxylate 

Relevant academic research and scientific papers

Pyrrolopyrimidine-inhibitors with hydantoin moiety as spacer can explore P4/S4 interaction on plasmin

In the development of plasmin inhibitors, a novel chemotype, pyrrolopyrimidine scaffold possessing two motifs, a hydantoin-containing P4 moiety and a warhead-containing P1 moiety, is uncovered. A unique feature of the new line of the plasmin inhibitors is